Nemluvio 30 mg lyophilized powder for injection (dual-chamber prefilled pen contains powder and diluent) Images

Generic Name: nemolizumab

This medication has been identified as Nemluvio 30 mg lyophilized powder for injection (dual-chamber prefilled pen contains powder and diluent). It is supplied by Galderma Laboratories, L.P.

Nemluvio is used in the treatment of Prurigo Nodularis; Atopic Dermatitis and belongs to the drug class interleukin inhibitors. Nemluvio 30 mg lyophilized powder for injection (dual-chamber prefilled pen contains powder and diluent) is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Nemluvio

Generic Name

nemolizumab

Strength

30 mg lyophilized powder for injection (dual-chamber prefilled pen contains powder and diluent)

Availability

Prescription only

Drug Class

Interleukin inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

Galderma Laboratories, L.P.

National Drug Code (NDC)

00299-6220

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer